Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC.SI · Entity 5607 | Director | June 26, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SHOULDER INNOVATIONS, INC.
Report date June 26, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,712 |
Reported balance
After 2026-06-26 transaction · row 1
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 5,046 · Balance 18,712 F1: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Inspire Medical Systems, Inc.
Report date February 13, 2026 · Filed February 18, 2026
Section 16 reporting ended · disclosed 2026-02-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,988 |
Reported balance
After 2026-02-13 transaction · row 1
1 source rowRow 1 · 2026-02-13 · Tax withholding · Disposed 579 · Balance 43,988 F1: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 1,475 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,475 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 1,475 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,475 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jun 29, 2026 20:21 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GrantCommon Stock | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001737133-26-000003 · wk-form4_1782764503.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,712 F1 · shares: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:34 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 1,000 | $14.84 | $14,840.00 |
DisclosureSEC source: 0001737133-26-000001 · wk-form4_1773783266.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,666 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 579 | $59.76 | $34,601.04 |
DisclosureSEC source: 0001104659-26-017053 · tm266746-7_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,988 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 327 | $66.33 | $21,689.91 |
DisclosureSEC source: 0001104659-26-013512 · tm266005-6_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,567 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. F2 · balance_after: Includes 27 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2025. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 00:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11,000 | $93.39 | $1,027,290.00 |
DisclosureSEC source: 0001104659-25-086559 · tm2525085-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,867 Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,159 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · derivative · entry 11 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,159 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17,849 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,849 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 276 | $90.28 | $24,917.28 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,867 F2 · shares: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 2,455 | $90.21 | $221,465.55 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,143 F2 · shares: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 2,649 | $90.24 | $239,045.76 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,598 F2 · shares: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 7,159 | $42.15 | $301,751.85 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 17,849 | $71.00 | $1,267,279.00 |
DisclosureSEC source: 0001104659-25-081406 · tm2524018-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 5,000 | $15.00 | $75,000.00 |
DisclosureSEC source: 0001641172-25-022244 · ownership.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,666 Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GrantCommon Stock | 7,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-022244 · ownership.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,666 F1 · shares: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2026 or August 1, 2026. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 2,200 | $186.45 | $410,190.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,126 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,326 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by son Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by son Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by son Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by daughter Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,174 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014866 · tm256927-6_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,674 F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 314 | $182.15 | $57,195.10 |
DisclosureSEC source: 0001104659-25-014866 · tm256927-6_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,598 F1 · balance_after: Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By son Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By son Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By son Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By daughter Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,771 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 15,000 | $230.03 | $3,450,450.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,271 F1 · kind: Reflects shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.82. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,376 | $0.00 Strike: $194.87 | $0.00 |
DisclosureSEC source: 0001104659-24-022563 · tm245999-4_4seq1.xml · derivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,376 Underlying: Common Stock · 4,376 shares Expires 2034-02-09 F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:39 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-022563 · tm245999-4_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,271 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022080 · tm236006-6_4seq1.xml · derivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 01:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,693 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-23-007634 · tm234399-2_4seq1.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,159 Underlying: Common Stock · 2,693 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 01:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 117 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-23-007634 · tm234399-2_4seq1.xml · derivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,849 Underlying: Common Stock · 117 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 20,000 underlying shares on December 16, 2020 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 01:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,290 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-23-007634 · tm234399-2_4seq1.xml · derivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,290 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 01:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,693 | $42.15 | $113,509.95 |
DisclosureSEC source: 0001104659-23-007634 · tm234399-2_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 01:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 117 | $71.00 | $8,307.00 |
DisclosureSEC source: 0001104659-23-007634 · tm234399-2_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 01:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,290 | $10.38 | $34,150.20 |
DisclosureSEC source: 0001104659-23-007634 · tm234399-2_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11,977 | $250.03 | $2,994,609.31 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,387 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.25, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 523 | $250.00 | $130,750.00 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,364 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 05, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,225 Read SEC document |
| January 05, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,225 Read SEC document |
| January 05, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,225 Read SEC document |
| January 05, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 1,225 Read SEC document |
| January 05, 2023 Filed Jan 13, 2023 21:59 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-003858 · tm233471-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,887 F1 · balance_after: Includes (i) 80 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2022 and (ii) 31 shares acquired under the Company Plan on December 31, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 101 | $255.99 | $25,854.99 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,176 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 4,037 | $257.90 | $1,041,142.30 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,277 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.04 to $258.03. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,362 | $258.50 | $1,386,077.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,314 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $259.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,500 | $259.46 | $1,427,030.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,676 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.10 to $259.675. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2022 Filed Apr 5, 2022 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 1,125 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.